Treatment results of oral verrucous carcinoma and its biological behavior

Oral Oncology

Volumn 40, Issue 8, 2004, Pages 793-797

  Ogawa, A ^a   Fukuta, Y ^a   Nakajima, T ^a   Kanno, S M ^a   Obara, A ^a   Nakamura, K ^a   Mizuki, H ^a   Takeda, Y ^a   Satoh, M ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

CD44v9, PCNA; Oral verrucous carcinoma; p53 Protein; Treatment result

Indexed keywords

COBALT 60; FLUOROURACIL; HERMES ANTIGEN; PEPLEOMYCIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RISK; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; SQUAMOUS CELL CARCINOMA; TUMOR CELL; VERRUCOUS CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; CARCINOMA, VERRUCOUS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53;

EID: 4043181981     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2004.01.008     Document Type: Article

References (10)

1. Batsakis J.G., Hybels R., Crissman J.D., Rice D.H. The pathology of head and neck tumors: verrucous carcinoma. Part 15. Head Neck Surg. 5(September/October):1982;29-38
2. Koch B.B., Trask D.K., Hoffman H.T., Karnell L.H., Robinson R.A., Zen W. National survey of head and neck verrucous carcinoma: pattern of presentation, care, and outcome. Cancer. 92(1):2001;110-120
3. Tharp M.E., Shidnia H. Radiotherapy in the treatment of verrucous carcinoma of the head and neck. Laryngoscope. 104(1):1995;391-396
4. Ferlito A., Rinald A., Mannarà G.M. Is primary radiotherapy an appropriate option for the treatment of verrucous carcinoma of the head and neck? J. Laryngol. Otol. 112(2):1998;132-139
5. Sobin L.H., Wittekind C.H. TNM classification of malignant tumors. 5th ed.:1997;Wiley-Liss, New York
6. Kaplan E.S., Meier P. Non-parametric estimations from incomplete observations. Am. Stat. Assoc. J. 34:1958;457-482
7. Shin D.M., Lee J.S., Lippman S.M., Lee J.J., Tu Z.N., Choi G., et al. p53 Expression: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma. JNCI. 88(8):1996;519-529
8. Sato S., Miyauchi M., Takekoshi T., Zhao M., Kudo Y., Ogawa I., et al. Reduced expression of CD44 variant 9 is related to lymph node metastasis and poor survival in squamous cell carcinoma of tongue. Oral Oncol. 36(6):2000;545-549
9. Sakurai K., Urade M., Takahashi Y., Kishimoto H., Noguchi K., Yasoshima H., et al. Increased expression of c-erb B-3 protein and proliferating cell nuclear antigen during development of verrucous carcinoma of the oral mucosa. Cancer. 89(12):2000;2597-2606
10. Vidyasagar M.S., Fernandes D.J., Pai Kasturi D., Akhileshwaran R., Rao K., Rao S., et al. Radiotherapy and verrucous carcinoma of the oral cavity. A study of 107 cases. Acta Oncol. 31(1):1992;43-47